Erythropoietin for Prevention or Treatment of anemia in Cancer Patients Undergoing Radiotherapy; Time to Pause and think !

ARUN GOEL; DINESH SINGH; M NANDY

doi:10.1055/s-0041-1733082

Indian Journal of Medical and Paediatric Oncology, Table of Contents

CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2004; 25(03): 55-58
DOI: 10.1055/s-0041-1733082

Selected Summary

Erythropoietin for Prevention or Treatment of anemia in Cancer Patients Undergoing Radiotherapy; Time to Pause and think !

Authors

ARUN GOEL

Departments of Surgical Oncoogy, Dharamshila Cancer Hospital & Research Centre Vasundhara Enclave, Delhi - 110096, India
DINESH SINGH

Department of Radiation Oncology, Dharmshila Cancer Hospital and Research Centre, Vasundhara Enclave, Delhi-110096, India
M NANDY

Department of Medical Oncology, Dharmshila Cancer Hospital and Research Centre, Vasundhara Enclave, Delhi-110096, India

References
1 Hockel M, Vaupel P. Tumour hypoxia: Definitions and current clinical, biological and molecular aspects. J Natl Cancer Inst. 2001; 93: 266-76.
2 Kelleher DK, Matthiensen U, Thews O, Vaupel P. Blood flow, oxygenation status and bioenergetic status of tumours after erythropoietin treatment in normal and anemic rats. Cancer Res, 1996; 56: 4728-34.
3 Evans IC, Bergsjo P. The influence of anemia on the results of radiotherapy in carcinoma of the cervix, Radiology, 1965;84: 709-17.
4 Overgaard J. The influence of hemoglobin concentrations on the response to radiotherapy. Scand J Clin Lab Invest, 1988; 48: 49-53.
5 Lee WR, Berkey B, Marcial V, et al. Anemia is associated with decreased survival and increased loco regional failure in patients with locally advanced head & neck carcinoma: a secondary analysis of RTOG 85-27. Int J Radiat Oncol Biol Phys, 1998; 42:1069-75
6 Yip SS. Harper PG. Effect of treatment with rhEPO on quality of life in anemic cancer patients. In Nowrousian MR (Ed): Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology, springer Wien New York; 2002; pp: 405-24
7 Glaser CM, Millesi W, Kornek GV, et al. Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemo radiation therapy for squamous cell carcinoma of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys, 2001; 50: 705- 15
8 Littlewood TJ, Bajetta E, Nor tier JW, Vercammen E, Rapoport B. Effects of epoietin alpha on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol, 2001; 19: 2865-74
9 Wun T, Law L, Harvey D, et al. Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin. Cancer2003; 98:1514-20.
10 Senzer N. Rationale for a phase III study of erythropoietin as a neurocognitive protectant in patients with lung cancer receiving prophylactic cranial irradiation. Semin Oncol 2002; 29: (6 SuppI) 47-52.